Non-Interventional Post Marketing Surveillance Study To Observe The Safety And Efficacy Of Vfend® Tablet In Korea
NCT01073631 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 543
Last updated 2012-06-07
Summary
This is a non-interventional study of voriconazole tablet in Korea which is mandated by the Korean government agency.
Conditions
- Serious Fungal Infections
Interventions
- DRUG
-
voriconazole tablet
200 mg PO bid (orally, twice a day)
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-03-31
- Primary Completion
- 2009-10-31
- Completion
- 2009-10-31
More Related Trials
-
Vfend Special Investigation For Prophylaxis
NCT02674685 ·Status: COMPLETED
-
Vfend Special Investigation For Pediatric - Observational
NCT02554656 ·Status: COMPLETED
-
Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteers
NCT02631954 ·Status: COMPLETED ·Phase: PHASE1
-
Open, Non Comparative Study Of Voriconazole In Slovak Patients With Very High Risk Of Developing An Invasive Fungal Infection
NCT01137292 ·Status: COMPLETED
-
Therapeutic Drug Monitoring of Voriconazole
NCT00890708 ·Status: COMPLETED ·Phase: NA
-
A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood.
NCT00163111 ·Status: COMPLETED ·Phase: PHASE3
-
Influence of Drug-drug Interactions on the Pharmacokinetics (PK) of Voriconazole
NCT01080651 ·Status: COMPLETED ·Phase: PHASE1
-
Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To 11 Years Old Who Are At High Risk For Systemic Fungal Infection
NCT00739934 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetics of Two Different Formulation of Voriconazole
NCT02912156 ·Status: COMPLETED ·Phase: PHASE4
-
A Study To Assess The Efficacy And Safety Of Voriconazole In Chinese Patients With Serious Deep Tissue Fungal Infections
NCT00288197 ·Status: COMPLETED ·Phase: PHASE4
-
Influence of SLCO2B1 Polymorphism on the PK of Voriconazole in CYP2C19 PM
NCT02906176 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Pharmacokinetic Properties of SYP-1018 (Voriconazole-loaded PNP) and Voriconazole (Vfend)
NCT01657201 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetic And Safety Study Of Voriconazole In Healthy Male And Female Adults
NCT00855101 ·Status: COMPLETED ·Phase: PHASE1
-
An Open-Label Study To Assess The Pharmacokinetics, Safety And Toleration Of Vfend®; Following Multiple Dosing With Vfend
NCT00150319 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Influence of CYP2C19 Genotype on the Pharmacokinetics (PK) of Voriconazole
NCT00942773 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Study on Tolerance and Pharmacokinetics of Voriconazole for Injection in Healthy Subjects
NCT05330000 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial Comparing Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosing
NCT01416025 ·Status: COMPLETED ·Phase: PHASE4
-
Post Marketing Surveillance (PMS) Study of Cresemba in Korea.
NCT04744454 ·Status: COMPLETED
-
Determination of Voriconazole Levels in Saliva - Validation in Specific Subsets of Patients
NCT01418846 ·Status: COMPLETED
-
A Study Of The Safety, Tolerability And Effective Of Voriconazole For The Treatment Of Serious Candida Infection And Candida Infection Of The Throat In Pediatric Patients
NCT01092832 ·Status: TERMINATED ·Phase: PHASE3
-
Preliminary Experience of Routine Voriconazole Therapeutic Drug Monitoring (TDM) in a Tertiary Care Centre
NCT01418833 ·Status: COMPLETED
-
A Study Of Indian Patients Receiving Therapy For Systemic Fungal Infections
NCT00721578 ·Status: COMPLETED
-
A Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Children
NCT00174473 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Voriconazole For Chronic Bronchopulmonary Aspergillosis
NCT00159822 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Single Ascending Dose and Multiple Ascending Dose Study of Voriconazole Inhalation Powder in Healthy Adult Subjects
NCT04872231 ·Status: COMPLETED ·Phase: PHASE1